Induction of tenascin in healing wounds

The distribution of the extracellular matrix glycoprotein, tenascin, in normal skin and healing skin wounds in rats, has been investigated by immunohistochemistry. In normal skin, tenascin was sparsely distributed, predominantly in association with basement membranes. In wounds, there was a marked increase in the expression of tenascin at the wound edge in all levels of the skin. There was also particularly strong tenascin staining at the dermal-epidermal junction beneath migrating, proliferating epidermis. Tenascin was present throughout the matrix of the granulation tissue, which filled full-thickness wounds, but was not detectable in the scar after wound contraction was complete. The distribution of tenascin was spatially and temporally different from that of fibronectin, and tenascin appeared before laminin beneath migrating epidermis. Tenascin was not entirely codistributed with myofibroblasts, the contractile wound fibroblasts. In EM studies of wounds, tenascin was localized in the basal lamina at the dermal-epidermal junction, as well as in the extracellular matrix of the adjacent dermal stroma, where it was either distributed homogeneously or bound to the surface of collagen fibers. In cultured skin explants, in which epidermis migrated over the cut edge of the dermis, tenascin, but not fibronectin, appeared in the dermis underlying the migrating epithelium. This demonstrates that migrating, proliferating epidermis induces the production of tenascin. The results presented here suggest that tenascin is important in wound healing and is subject to quite different regulatory mechanisms than is fibronectin.

[1]  M. Kusakabe,et al.  Epithelial induction of stromal tenascin in the mouse mammary gland: from embryogenesis to carcinogenesis. , 1988, Developmental biology.

[2]  G. Edelman,et al.  Molecular forms, binding functions, and developmental expression patterns of cytotactin and cytotactin-binding proteoglycan, an interactive pair of extracellular matrix molecules , 1988, The Journal of cell biology.

[3]  W. Halfter,et al.  The distribution of tenascin coincides with pathways of neural crest cell migration. , 1988, Development.

[4]  I. Thesleff,et al.  Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro , 1987, The Journal of cell biology.

[5]  I. Thesleff,et al.  Changes in the distribution of tenascin during tooth development. , 1987, Development.

[6]  Yann Barrandon,et al.  Cell migration is essential for sustained growth of keratinocyte colonies: The roles of transforming growth factor-α and epidermal growth factor , 1987, Cell.

[7]  M. Sporn,et al.  Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. , 1987, Science.

[8]  Y. Kawarada,et al.  Tenascin is a stromal marker for epithelial malignancy in the mammary gland. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Chiquet‐Ehrismann,et al.  Epithelial-mesenchymal interactions in the developing kidney lead to expression of tenascin in the mesenchyme , 1987, The Journal of cell biology.

[10]  F. Pope Connective Tissue Disease: Molecular Pathology of the Extracellular Matrix , 1987 .

[11]  M. Chiquet,et al.  A major, six‐armed glycoprotein from embryonic cartilage. , 1987, The EMBO journal.

[12]  C. Doillon,et al.  Actin filaments in normal dermis and during wound healing. , 1987, The American journal of pathology.

[13]  R. Chiquet‐Ehrismann,et al.  Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis , 1986, Cell.

[14]  P. Knox,et al.  Role of fibronectin in the migration of fibroblasts into plasma clots , 1986, The Journal of cell biology.

[15]  J. McPherson,et al.  Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta. , 1986, The Journal of biological chemistry.

[16]  R. Marks,et al.  Factor XIII inhibits epidermal cell migration in vitro. , 1984, The Journal of investigative dermatology.

[17]  M. Chiquet,et al.  Chick myotendinous antigen. II. A novel extracellular glycoprotein complex consisting of large disulfide-linked subunits , 1984, The Journal of cell biology.

[18]  M. Chiquet,et al.  Chick myotendinous antigen. I. A monoclonal antibody as a marker for tendon and muscle morphogenesis , 1984, The Journal of cell biology.

[19]  P. Baur,et al.  The myofibroblast anchoring strand--the fibronectin connection in wound healing and the possible loci of collagen fibril assembly. , 1983, The Journal of trauma.

[20]  D. Bigner,et al.  Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. , 1983, Cancer research.

[21]  G. Gabbiani,et al.  The role of cytoskeletal and cytocontractile elements in pathologic processes. , 1983, The American journal of pathology.

[22]  F. Grinnell,et al.  Distribution of fibronectin during wound healing in vivo. , 1981, The Journal of investigative dermatology.

[23]  A. Vaheri,et al.  Sequential appearance of fibronectin and collagen in experimental granulation tissue. , 1980, Laboratory investigation; a journal of technical methods and pathology.

[24]  J. Seyer,et al.  Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[25]  B. Hirschel,et al.  Contraction of Granulation Tissue in vitro: Similarity to Smooth Muscle , 1971, Science.

[26]  • Epidermis,et al.  WOUND healing. , 1959, The Medical journal of Australia.